自己抗体に注目した新規治療方法の研究開発を行う京都大学発スタートアップです。創薬・医療機器・診断薬などの治療に関係する製品を開発しています。
R&D start-up company of pharmaceutical/medical device/ diagnostics from Kyoto University. We focus on disease specific autoantibodies as new "omics"
Company Details
- Employees
- 4
- Founded
- -
- Address
- Yoshida Shimoadachicho, Kyoto,kyoto 6068304,japan
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- 自己抗体, バイオテクノロジー, 免疫.
- HQ
- kyoto, kyoto
Link Therapeutics 株式会社 Questions
Link Therapeutics 株式会社's website is https://www.link-therapeutics.com/
Link Therapeutics 株式会社's LinkedIn profile is https://jp.linkedin.com/company/link-therapeutics-%E6%A0%AA%E5%BC%8F%E4%BC%9A%E7%A4%BE
Link Therapeutics 株式会社 has
4 employees.
View email and phone details for 4
employees at Link Therapeutics 株式会社.
Link Therapeutics 株式会社's industry is
Biotechnology Research
Link Therapeutics 株式会社's top competitors are
S2s Japan,
Optieum Biotechnologies Inc.,
Kyoto University Innovation Capital Co., Ltd,
T Cell Nouveau,
Regcell,
An Venture Partners,
Curreio, Inc.,
Somite Ai,
Iac-Kyoto University,
Scad (Stem Cell & Device Laboratory, Inc. ).
Link Therapeutics 株式会社's categories are Biotechnology Research
Link Therapeutics 株式会社's founding year is 2022
